Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Respiratory symbols : SRNE save search
Sorrento Announces Enrollment of First Subject in Brazil Phase 2 Study of COVI-MSC for Treatment of COVID-19 Associated Acute Respiratory Distress in ICU Patients
Published: 2021-09-02 (Crawled : 16:00) - globenewswire.com
SRNE | $0.02 33.33% -8.85% 97K
|
Health Technology
|
| O: 0.22%
H: 1.42%
C: -0.11%
covid treatment phase 2 brazil respiratory enroll
Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Pivotal Clinical Trial of COVI-MSC™ in Hospitalized COVID-19 Patients With Acute Respiratory Distress Syndrome
Published: 2021-05-20 (Crawled : 13:15) - globenewswire.com
SRNE | $0.02 33.33% -8.85% 97K
|
Health Technology
|
| O: 1.43%
H: 4.24%
C: 1.98%
covid phase 2 brazil respiratory trial authorized syndros
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.